Microfluidic platform versus conventional real-time polymerase chain reaction for the detection of Mycoplasma pneumoniae in respiratory specimens

Diagnostic Microbiology and Infectious Disease

Volumn 67, Issue 1, 2010, Pages 22-29

  Wulff Burchfield, Elizabeth ^a   Schell, Wiley A ^b   Eckhardt, Allen E ^c   Pollack, Michael G ^c   Hua, Zhishan ^c   Rouse, Jeremy L ^c   Pamula, Vamsee K ^c   Srinivasan, Vijay ^c   Benton, Jonathan L ^b   Alexander, Barbara D ^b   Wilfret, David A ^b   Kraft, Monica ^b   Cairns, Charles B ^d   Perfect, John R ^b   Mitchell, Thomas G ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Advanced Liquid Logic Inc   (United States)

^d UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

Community acquired pneumonia; Diagnostic microbiology; DNA based diagnostics; Mycoplasma pneumoniae; Real time PCR

Indexed keywords

BACTERIAL DNA; STREPTAVIDIN;

ARTICLE; AUTOMATION; BACTERIUM DETECTION; BIOTINYLATION; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA EXTRACTION; DNA PROBE; GENE AMPLIFICATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MICROFLUIDIC ANALYSIS; MOLECULAR PROBE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NASOPHARYNGEAL ASPIRATION; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYSTEM; SENSITIVITY ANALYSIS; SIMULATION;

AUTOMATION; BACTERIOLOGICAL TECHNIQUES; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; MICROFLUIDICS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOPLASMA PNEUMONIAE; NASOPHARYNX; PNEUMONIA, MYCOPLASMA; POINT-OF-CARE SYSTEMS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 77951499668     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.12.020     Document Type: Article

References (51)

1. Auroux P.A., Koc Y., deMello A., Manz A., Day P.J. Miniaturised nucleic acid analysis. Lab Chip 2004, 4:534-546.
2. Beersma M.F.C., Dirven K., van Dam A.P., Templeton K.E., Claas E.C.J., Goossens H. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard". J. Clin. Microbiol. 2005, 43:2277-2285.
3. Bernet C., Garret M., de Barbeyrac B., Bébéar C.M., Bonnet J. Detection of Mycoplasma pneumoniae by using the polymerase chain reaction. J. Clin. Microbiol. 1989, 27:2492-2496.
4. Chen L., Manz A., Day P.J. Total nucleic acid analysis integrated on microfluidic devices. Lab Chip 2007, 7:1413-1423.
5. Cler L., Bu D., Lewis C., Euhus D. A comparison of five methods for extracting DNA from paucicellular clinical samples. Mol. Cell. Probes 2006, 20:191-196.
6. Daxboeck F., Krause R., Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin. Microbiol. Infect. 2003, 9:263-273.
7. Dumke R., Jacobs E. Comparison of commercial and in-house real-time PCR assays used for detection of Mycoplasma pneumoniae. J. Clin. Microbiol. 2009, 47:441-444.
8. Dumke R., Schurwanz N., Lenz M., Schuppler M., Luck C., Jacobs E. Sensitive detection of Mycoplasma pneumoniae in human respiratory tract samples by optimized real-time PCR approach. J. Clin. Microbiol. 2007, 45:2726-2730.
9. Fair R.B. Digital microfluidics: is a true lab-on-a-chip possible?. Microfluidics Nanofluidics 2007, 3:245-281.
10. Fee C., Weber E.J. Identification of 90% of patients ultimately diagnosed with community-acquired pneumonia within four hours of emergency department arrival may not be feasible. Ann. Emerg. Med. 2007, 49:553-559.
11. Gullsby K., Storm M., Bondeson K. Simultaneous detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae by use of molecular beacons in a duplex real-time PCR. J. Clin. Microbiol. 2008, 46:727-731.
12. Hagaman J.T., Rouan G.W., Shipley R.T., Panos R.J. Admission chest radiograph lacks sensitivity in the diagnosis of community-acquired pneumonia. Am. J. Med. Sci. 2009, 337:236-240.
13. Herold C.J., Sailer J.G. Community-acquired and nosocomial pneumonia. Eur. Radiol. 2004, 14(Suppl.3):E2-E20.
14. Hua Z., Rouse J.L., Eckhardt A.E., Srinivasan V., Pamula V.K., Schell W.A., Benton J.L., Mitchell T.G., Pollack M.G. Multiplexed real-time polymerase chain reaction on a digital microfluidic platform. Anal Chem. 2010, 82:2310-2316.
15. Huang H.H., Zhang Y.Y., Xiu Q.Y., Zhou X., Huang S.G., Lu Q., Wang D.M., Wang F. Community-acquired pneumonia in Shanghai, China: microbial etiology and implications for empirical therapy in a prospective study of 389 patients. Eur. J. Clin. Microbiol. Infect. Dis. 2006, 25:369-374.
16. Ieven M., Goossens H. Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory. Clin. Microbiol. Rev. 1997, 10:242-256.
17. Jokinen C., Heiskanen L., Juvonen H., Kallinen S., Kleemola M., Koskela M., Leinonen M., Rönnberg P.R., Saikku P., Sten M., Tarkiainen A., Tukiainen H., Pyorala K., Makela P.H. Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin. Infect. Dis. 2001, 32:1141-1154.
18. Kashyap B., Kumar S., Sethi G.R., Das B.C., Saigal S.R. Comparison of PCR, culture & serological tests for the diagnosis of Mycoplasma pneumoniae in community-acquired lower respiratory tract infections in children. Indian J. Med. Res. 2008, 128:134-139.
19. Kenny G.E., Kaiser G.G., Cooney M.K., Foy H.M. Diagnosis of Mycoplasma pneumoniae pneumonia: sensitivities and specificities of serology with lipid antigen and isolation of the organism on soy peptone medium for identification of infections. J. Clin. Microbiol. 1990, 28:2087-2093.
20. Khanna M., Fan J., Pehler-Harrington K., Waters C., Douglass P., Stallock J., Henrickson K.J., Kehl S. The Pneumoplex assays, a multiplex PCR-enzyme hybridization assay that allows simultaneous detection of five organisms, Mycoplasma pneumoniae, Chlamydia (Chlamydophila) pneumoniae, Legionella pneumophila, Legionella micdadei, and Bordetella pertussis, and its real-time counterpart. J. Clin. Microbiol. 2005, 43:565-571.
21. Kong F., Gordon S., Gilbert G.L. Rapid-cycle PCR for detection and typing of Mycoplasma pneumoniae in clinical specimens. J. Clin. Microbiol. 2000, 38:4256-4259.
22. Korppi M., Heiskanen-Kosma T., Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology 2004, 9:109-114.
23. Kumar S., Wang L., Fan J., Kraft A., Bose M.E., Tiwari S., Van Dyke M., Haigis R., Luo T., Ghosh M., Tang H., Haghnia M., Mather E.L., Weisburg W.G., Henrickson K.J. Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients by using a multiplex reverse transcription-PCR assay with manual (enzyme hybridization) or automated (electronic microarray) detection. J. Clin. Microbiol. 2008, 46:3063-3072.
24. Kung C.M., Wang H.L. Seroprevalence of Mycoplasma pneumoniae in healthy adolescents in Taiwan. Jpn. J. Infect. Dis. 2007, 60:352-354.
25. Lieberman D., Shvartzman P., Korsonsky I., Lieberman D. Diagnosis of ambulatory community-acquired pneumonia. Comparison of clinical assessment versus chest X-ray. Scand. J. Prim. Health Care 2003, 21:57-60.
26. Liu F.-C., Chen P.-Y., Huang F.-L., Tsai C.-R., Lee C.-Y., Wang L.-C. Rapid diagnosis of Mycoplasma pneumoniae infection in children by polymerase chain reaction. J. Microbiol. Immunol. Infect. 2007, 40:507-512.
27. Liu F.-C., Chen P.-Y., Huang F.-L., Tsai C.-R., Lee C.-Y., Lin C.F. Do serological tests provide adequate rapid diagnosis of Mycoplasma pneumoniae infection?. Jpn. J. Infect. Dis. 2008, 61:397-399.
28. Loens K., Ursi D., Goossens H., Ieven M. Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections. J. Clin. Microbiol. 2003, 41:4915-4923.
29. Luna C.M., Famiglietti A., Absi R., Videla A.J., Nogueira F.J., Fuenzalida A.D., Gené R.J. Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest 2000, 118:1344-1354.
30. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., Dowell S.F., File T.M., Musher D.M., Niederman M.S., Torres A., Whitney C.G. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007, 44(Suppl.2):S27-S72.
31. Martínez M.A., Ruiz M., Zunino E., Luchsinger V., Avendaño L.F. Detection of Mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J. Med. Microbiol. 2008, 57:1491-1495.
32. Morozumi M., Ito A., Murayama S.Y., Hasegawa K., Kobayashi R., Iwata S., Kawamura N., Kuroki H., Nakayama E., Tajima T., Ubukata K. Assessment of real-time PCR for diagnosis of Mycoplasma pneumoniae pneumonia in pediatric patients. Can. J. Microbiol. 2006, 52:125-129.
33. Ngeow Y.F., Suwanjutha S., Chantarojanasriri T., Wang F., Saniel M., Alejandria M., Hsueh P.-R., Ping-Ing L., Park S.C., Sohn J.W., Aziah A.M., Liu Y., Seto W.H., Ngan C.C., Hadiarto M., Hood A., Cheong Y.M. An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia. Int. J. Infect. Dis. 2005, 9:144-153.
34. Ozaki T., Nishimura N., Ahn J., Watanabe N., Muto T., Saito A., Koyama N., Nakane K., Funahashi K. Utility of a rapid diagnosis kit for Mycoplasma pneumoniae pneumonia in children, and the antimicrobial susceptibility of the isolates. J. Infect. Chemother. 2007, 13:204-207.
35. Plouffe J.F. Importance of atypical pathogens of community-acquired pneumonia. Clin. Infect. Dis. 2000, 31(Suppl.2):S35-S39.
36. Plouffe J.F., Martin D.R. Pneumonia in the emergency department. Emerg. Med. Clin. North Am. 2008, 26:389-411.
37. Pollack M.G., Fair R.B., Shenderov A.D. Electrowetting-based actuation of liquid droplets for microfulidic applications. Appl. Phys. Lett. 2000, 77:1725-1726.
38. Pollack M.G., Shenderov A.D., Fair R.B. Electrowetting-based actuation of droplets for integrated microfluidics. Lab Chip 2002, 2:96-101.
39. Reechaipichitkul W., Lulitanond V., Tantiwong P., Saelee R., Pisprasert V. Etiologies and treatment outcomes in patients hospitalized with community-acquired pneumonia (CAP) at Srinagarind Hospital, Khon Kaen, Thailand. Southeast Asian J. Trop. Med. Public Health 2005, 36:156-161.
40. Sista R.S., Hua Z., Thwar P., Sudarsan A., Srinivasan V., Eckhardt A.E., Pollack M.G., Pamula V.K. Development of a digital microfluidic platform for point of care testing. Lab Chip 2008, 8:2091-2104.
41. Skakni L., Sardet A., Just J., Landman-Parker J., Costil J., Moniot-Ville N., Bricout F., Garbarg-Chenon A. Detection of Mycoplasma pneumoniae in clinical samples from pediatric patients by polymerase chain reaction. J. Clin. Microbiol. 1992, 30:2638-2643.
42. Templeton K.E., Scheltinga S.A., Graffelman A.W., Van Schie J.M., Crielaard J.W., Sillekens P., van den Broek P.J., Goossens H., Beersma M.F.C., Claas E.C.J. Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae. J. Clin. Microbiol. 2003, 41:4366-4371.
43. Thurman K.A., Walter N.D., Schwartz S.B., Mitchell S.L., Dillon M.T., Baughman A.L., Deutscher M.P., Fulton J.P., Tongren J.E., Hicks L.A., Winchell J.M. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin. Infect. Dis. 2009, 48:1244-1249.
44. Tsolia M.N., Psarras S., Bossios A., Audi H., Paldanius M., Gourgiotis D., Kallergi K., Kafetzis D.A., Constantopoulos A., Papadopoulos N.G. Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin. Infect. Dis. 2004, 39:681-686.
45. Ursi D., Dirven K., Loens K., Ieven M., Goossens H. Detection of Mycoplasma pneumoniae in respiratory samples by real-time PCR using an inhibition control. J. Microbiol. Meth. 2003, 55:149-153.
46. Venditti M., Falcone M., Corrao S., Licata G., Serra P. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann. Intern. Med. 2009, 150:19-26.
47. Waites K.B., Katz B., Schelonka R.L. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin. Microbiol. Rev. 2005, 18:757-789.
48. Waris M.E., Toikka P., Saarinen T., Nikkari S., Meurman O., Vainionpaa R., Mertsola J., Ruuskanen O. Diagnosis of Mycoplasma pneumoniae pneumonia in children. J. Clin. Microbiol. 1998, 36:3155-3159.
49. Watkins-Riedel T., Stanek G., Daxboeck F. Comparison of SeroMP IgA with four other commercial assays for serodiagnosis of Mycoplasma pneumoniae pneumonia. Diagn. Microbiol. Infect. Dis. 2001, 40:21-25.
50. Winchell J.M., Thurman K.A., Mitchell S.L., Thacker W.L., Fields B.S. Evaluation of three real-time PCR assays for detection of Mycoplasma pneumoniae in an outbreak investigation. J. Clin. Microbiol. 2008, 46:3116-3118.
51. Zhang C., Xu J., Ma W., Zheng W. PCR microfluidic devices for DNA amplification. Biotechnol. Adv. 2006, 24:243-284.